eGenesis Appoints Industry Veteran Paul Sekhri as President and Chief Executive Officer

CAMBRIDGE, Mass. – Jan. 17, 2019 – eGenesis, a biotechnology company revolutionizing the field of transplantation with its multiplexed gene editing platform, today announced the appointment of Paul Sekhri as president and chief executive officer, effective immediately.

Read More